Home » Stocks » ENDRA Life Sciences

ENDRA Life Sciences Inc. (NDRA)

Stock Price: $0.780 USD 0.050 (6.85%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 19.41M
Revenue (ttm) n/a
Net Income (ttm) -18.66M
Shares Out 24.88M
EPS (ttm) -1.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $0.780
Previous Close $0.730
Change ($) 0.050
Change (%) 6.85%
Day's Open 0.738
Day's Range 0.703 - 0.789
Day's Volume 177,909
52-Week Range 0.599 - 2.250

More Stats

Market Cap 19.41M
Enterprise Value 19.37M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 24.88M
Float 22.96M
EPS (basic) -2.15
EPS (diluted) -1.75
FCF / Share -0.75
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 577,777
Short Ratio 6.41
Short % of Float 2.52%
Beta 1.60
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 18.59
Revenue n/a
Operating Income -11.77M
Net Income -18.66M
Free Cash Flow -10.99M
Net Cash 32,026
Net Cash / Share 0.00
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -242.91%
ROE -1,030.95%
ROIC -3,917.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$5.08*
(551.28% upside)
Low
3.25
Current: $0.780
High
6.00
Target: 5.08
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue-0.010.350.521.41
Revenue Growth--98.24%-31.8%-63.44%-
Gross Profit-0.010.180.280.74
Operating Income-10.84-9.02-5.38-2.77-1.57
Net Income-17.53-9.80-5.38-2.78-2.28
Shares Outstanding7.504.502.760.722.32
Earnings Per Share-2.34-2.17-1.95-3.84-0.98
Operating Cash Flow-8.59-7.70-3.30-1.32-0.84
Capital Expenditures-0.04-0.10-0.01--0.13
Free Cash Flow-8.63-7.80-3.31-1.32-0.98
Cash & Equivalents6.176.475.600.140.02
Total Debt0.71--0.95-
Net Cash / Debt5.476.475.60-0.810.02
Assets7.187.226.120.490.49
Liabilities2.420.970.851.380.24
Book Value4.766.255.28-0.890.25
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ENDRA Life Sciences Inc.
Country United States
Employees 15
CEO Francois Michelon

Stock Information

Ticker Symbol NDRA
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: NDRA
IPO Date May 9, 2017

Description

ENDRA Life Sciences develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.